BCR–ABL1 transcript doubling time as a predictor for treatment‐free remission failure after imatinib discontinuation in chronic myeloid leukaemia in chronic phase
Kim, Dennis Dong Hwan, Kim, Taehyung Simon, Atenafu, Eshetu G., Novitzky Basso, Igor, Forrest, Donna, Bence‐Bruckler, Isabelle, Savoie, Lynn, Busque, Lambert, Keating, Mary‐Margaret, Delage, Robert, Xenocostas, Anargyros, Liew, Elena, Paulson, Kristjan, Stockley, Tracy, Laneuville, Pierre, Lipton, Jeffrey H., Kamel‐Reid, Suzanne, Leber, Brian
Published in British journal of haematology (01.01.2022)
Published in British journal of haematology (01.01.2022)
Get full text
Journal Article
Evidence for positive selection on a number of MicroRNA regulatory interactions during recent human evolution
Li, Jingjing, Liu, Yu, Xin, Xiaofeng, Kim, Taehyung Simon, Cabeza, Eduardo Aguiar, Ren, Jie, Nielsen, Rasmus, Wrana, Jeffrey L, Zhang, Zhaolei
Published in PLoS genetics (01.03.2012)
Published in PLoS genetics (01.03.2012)
Get full text
Journal Article
The 17‐gene stemness score associates with relapse risk and long‐term outcomes following allogeneic haematopoietic cell transplantation in acute myeloid leukaemia
Kim, Dennis D. H., Novitzky Basso, Igor, Kim, Taehyung Simon, Yi, Seong Yoon, Kim, Kyoung Ha, Murphy, Tracy, Chan, Steven, Minden, Mark, Pasic, Ivan, Lam, Wilson, Law, Arjun, Michelis, Fotios V., Gerbitz, Armin, Viswabandya, Auro, Lipton, Jeffrey, Kumar, Rajat, Ng, Stanley W. K., Stockley, Tracy, Zhang, Tong, King, Ian, Mattsson, Jonas, Wang, Jean C. Y.
Published in EJHaem (01.08.2022)
Published in EJHaem (01.08.2022)
Get full text
Journal Article
In Vitro Evidence of Double Blockade of Asciminib with Reduced Dose of ATP-Binding Pocket Inhibitors in the Treatment of Chronic Myeloid Leukemia Harboring ABL1 Kinase Domain Mutation
Han, Ho-Jae, Jang, Hyeok-Jae, Yoo, Youngseok, Kim, Taehyung Simon, Kim, Jong-Won, Kim, Dennis Dong Hwan
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Acute Myeloid Leukemia (AML) Patients with Myelodysplasia (MDS) Related-Gene Mutations in First Complete Remission (CR1) Found to Have Benefit from Allogeneic Hematopoietic Stem Cell Transplant (HCT)
Sayyed, Ayman, Kim, Taehyung Simon, Park, Silvia, Ahn, Jae-Sook, Karsan, Aly, Gagnon, Marie-France, Bergeron, Julie, Kim, Hee-Je, Kim, Hyeoung-Joon, Sanford, David, Schuh, Andre C., Kim, Dennis Dong Hwan
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
The Presence of Somatic Mutations on Specific Pathways Such As Chromatin Modifier, Spliceosome, and Myeloid Transcription Factor at Diagnosis Was Found to Have Benefit from Allogeneic Hematopoietic Stem Cell Transplantation (HCT) in 1,228 Patients with Acute Myeloid Leukemia in First Complete Remission (CR1)
Sayyed, Ayman, Kim, Taehyung Simon, Park, Silvia, Ahn, Jae-Sook, Karsan, Aly, Gagnon, Marie-France, Bergeron, Julie, Kim, Hyeoung-Joon, Kim, Heeje, Sanford, David, Schuh, Andre C., Kim, Dennis Dong Hwan
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
The Presence of Somatic Mutation in Donor Does Not Affect Long-Term Outcomes in 339 Patients Following Allogeneic Hematopoietic Stem Cell Transplantation Using Uniform Fludarabine/Busulfan Myeloablative Conditioning and Cyclosporine/Methotrexate and ATG Gvhd Prophylaxis
Sayyed, Ayman, Lee, Hyewon, Kim, Taehyung Simon, Kim, Jaeyoon John, Pyne, Danielle, Kaushansky, Nathali, Brilon, Yardena, Chapal-Ilani, Noa, Biezuner, Tamir, Shlush, Liran I., Storek, Jan, Kim, Dennis Dong Hwan
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Is Allogeneic Hematopoietic Stem Cell Transplant (HCT) in First Remission Beneficial to Acute Myeloid Leukemia (AML) Patients with Isocitrate Dehydrogenase(IDH) Mutations?
Sayyed, Ayman, Kim, Taehyung Simon, Park, Silvia, Ahn, Jae-Sook, Karsan, Aly, Gagnon, Marie-France, Bergeron, Julie, Kim, Hyeoung-Joon, Kim, Heeje, Sanford, David, Schuh, Andre C., Kim, Dennis Dong Hwan
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Prognostic Analysis According to European Leukemianet 2022 Risk Stratification for Elderly Patients with Acute Myeloid Leukemia Treated with Decitabine
Kim, Mihee, Kim, Taehyung Simon, Ahn, Seo-Yeon, Jung, Sung-Hoon, Song, Ga-Young, Yang, Deok-Hwan, Lee, Je-Jung, Choi, Seunghyun, Kim, MiYeon, Ahn, Jae-Sook, Kim, Hyeoung-Joon, Kim, Dennis
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
The Prognostic Impact of HMGCLL1 Gene Variant on Treatment Outcomes in Chronic Myeloid Leukemia (CML) Patients: Adverse Impact on the Response, Failure, and Progression with Imatinib Which Can be Abrogated By the Use of 2nd Generation Tyrosine Kinase Inhibitor (TKI) Upfront Therapy
Perusini, Maria Agustina, Kim, Taehyung Simon, Žácková, Daniela, Pagnano, Katia B, Mayer, Jiří, Pavlovsky, Carolina, Ježíšková, Ivana, Kvetková, Anežka, Jurček, Tomáš, Moiraghi, Beatriz, Varela, Ana Ines, Bianchini, Michele, Lopes, Ana Beatriz Pascoal, Duarte, Gislaine B O, Yoo, Young Seok, Souza, Carmino Antonio, Medeiros, Jessie, Lee, Hye Won, Kim, Kyoung Ha, Yi, Seong Yoon, Chang, Myung Hee, Abelson, Sagi, Kim, Dennis Dong Hwan
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Somatic Mutations Are Frequently Detected in CML Patients before Treatment-Free Remission (TFR) Attempt with Tyrosine Kinase Inhibitor (TKI) Discontinuation but with Uncertain Predictive Value for Tfr Failure
Perusini, Maria Agustina, Pagnano, Katia B, Pavlovsky, Carolina, Moiraghi, Beatriz, Varela, Ana Ines, Bianchini, Michele, Mayer, Jiří, Žácková, Daniela, Kvetková, Anežka, Jurček, Tomáš, Ježíšková, Ivana, Lopes, Ana Beatriz Pascoal, Duarte, Gislaine B O, Souza, Carmino Antonio, Medeiros, Jessie J.F., Kim, Taehyung Simon, Yoo, Young Seok, Kim, Kyoung Ha, Lee, Hye Won, Chang, Myung Hee, Yi, Seong Yoon, Abelson, Sagi, Kim, Dennis
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Whole Exome Sequencing Reveals That DNMT3A and ASXL1 Mutation Are Involved in the Development of Tyrosine Kinase Inhibitor Resistance in Chronic Myeloid Leukemia Patients without ABL1 Tyrosine Kinase Domain Mutation
Kim, Taehyung Simon, Zhang, Zhaolei, Tyndel, Marc, Ahn, Jae-Sook, Choi, Seunghyun, Kim, Hyeoung Joon, Lipton, Jeffrey H., Kim, Dennis Dong Hwan
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article
Whole Exome Sequencing Reveals the Landscape of Clonal Evolution from MDS to AML Progression
Kim, Taehyung Simon, Zhang, Zhaolei, Tyndel, Marc, Ahn, Jae-Sook, Kim, Yeo-Kyeoung, Choi, Seung Hyun, Kim, Hyeoung-Joon, Lee, Moses, Choi, Murim, Lipton, Jeffrey H., Kim, Dennis Dong Hwan
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article